Last update:
Oncology news
A 'recipe book' for reprogramming cells into disease-fighting immune cells
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created a library of the 400 ...
8 hours ago
0
26
European women's lung cancer mortality rates predicted to level off by 2026
After increasing for more than 25 years, lung cancer death rates are finally leveling off among women in European Union (EU) countries apart from Spain, according to predictions of mortality rates from the disease for 2026.
1 hour ago
0
0
Shelf-stable mRNA delivery system targets bladder cancer cells without immune response
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University improves upon traditional methods of targeting bladder cancer cells with messenger RNA (mRNA) therapies.
8 hours ago
0
16
Color blindness may reduce early bladder cancer detection and survival
People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health records of hundreds of people found that those with color vision deficiency (CVD), or color blindness ...
Tumor cells steal immune mitochondria to aid lymph node spread
Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune function and activating cGAS-STING and type I interferon signaling that promotes lymph node metastasis.
Hyaluronic acid could be key to improving gynecological cancer treatment
A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using stabilized hyaluronic acid (sHA) gel as a rectal spacer during radiation treatment for gynecological cancers.
Jan 17, 2026
0
0
Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow. A team of researchers ...
Jan 17, 2026
0
0
Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome
The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The ...
Jan 16, 2026
0
12
Reversing immune suppression in pancreatic cancer could lead to novel therapies
In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer cells send out tiny particles that are packed with certain microRNA molecules, nearby immune cells ...
Jan 16, 2026
0
1
Dual therapy shows promise for childhood brain cancer
Researchers at the Children's Cancer Institute and UNSW Sydney have tested a new way of treating childhood brain cancer by combining two medicines in lab studies. They found using the two treatments together may work better ...
Jan 16, 2026
0
0
National genomic screening program could save thousands of Australians from preventable cancer and heart disease
Leading genomic health experts from Monash University are calling for urgent government funding to progress the development of a national preventive genomic testing program that would save thousands of Australians from conditions ...
Jan 16, 2026
0
0
How AI is transforming health care
By recognizing patterns in test results, AI can identify patients at risk of cancer, diabetes complications, heart disease and mental health issues.
Jan 16, 2026
0
0
Dormant cancer cells can change shape to survive immune system attack
Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune defenders and biding their time until conditions are ripe for establishing a new tumor elsewhere in ...
Jan 15, 2026
0
0
Study finds high blood pressure primes heart for damage from cancer drugs
Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than 30 years. Their extraordinary efficacy against numerous solid and hematologic tumors means that they ...
Jan 15, 2026
0
0
Potential tumor-suppressing gene identified in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct. Accounting for more than 90% of all pancreatic cancers, PDAC is extremely difficult ...
Jan 15, 2026
0
0
Finding new cell markers to track the most aggressive breast cancer in blood
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC is also more likely to metastasize, or travel through the bloodstream to spread to other organs, ...
Jan 15, 2026
0
0
Sugar structures on kidney cells predict immune therapy response, study finds
Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These antibodies activate the immune system and enable T cells to detect and destroy tumor cells.
Jan 15, 2026
0
0
Researchers reveal interplay between chronic pancreatic inflammation and early cancer development
Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the deadliest forms of cancer.
Jan 15, 2026
0
0
Physical activity linked to breast tissue composition and stress markers in teens
Recreational physical activity may be associated with breast tissue composition and biomarkers of stress in adolescent girls, according to a new study from Columbia University Mailman School of Public Health and the Herbert ...
Jan 15, 2026
0
0
Novel theranostic model shows curative potential for gastric and pancreatic tumors
A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, completely eradicating tumors in certain preclinical models. Targeting the well-defined and accessible biomarker ...
Jan 15, 2026
0
0
Predicting prostate cancer recurrence through power of AI
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic's Department of Radiation Oncology developed the PSA ...
Jan 15, 2026
0
0
Trial reveals gene variant may affect prostate cancer drug efficacy
Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that may inform how to optimize the dosing of abiraterone, a widely used hormone treatment for advanced ...
Jan 15, 2026
0
0
The protein periostin may promote the spread of pancreatic cancer—and pain—through nerves
A new Brazilian study has revealed the key role of the protein periostin and stellate pancreatic cells in allowing pancreatic cancer to infiltrate nerves and spread early, increasing the risk of metastasis. The research demonstrates ...
Jan 14, 2026
0
35
Bacterial toxin can counteract colorectal cancer growth
A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden. Systemic administration ...
Jan 14, 2026
0
65
Gut bacteria molecule boosts lung cancer treatment response
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy treatment in mice and can now be made into a drug for testing ...
Jan 14, 2026
0
50
